Gamida Cell to Present at BMO Capital Markets Prescriptions for Success Healthcare Conference


BOSTON--(BUSINESS WIRE)-- Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced that Julian Adams, Ph.D., the company’s chief executive officer, will participate in a fireside chat at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference on Wednesday, December 12th at 1:20 p.m. ET in New York, NY.

A live webcast of the presentation will be available on the Investors section of the Gamida Cell website, at and will be available for at least 30 days following the event.

About Gamida Cell
Gamida Cell is a clinical stage biopharmaceutical company leveraging its proprietary technology to develop cell therapies that are designed to cure cancer and rare, serious hematologic diseases. The company is leveraging its nicotinamide-, or NAM-, based cell expansion technology to develop a pipeline of products designed to address the limitations of cell therapies.


Investor and Media Inquiries:
Jaren Irene Madden


Source: Gamida Cell Ltd.

Back to news